Hovedindeksen (OSEBX.OL)

Close: 1 456.43 (+4.20), Apr 25, 2025
Weak Negative

Low risk

Automatic technical analysis. Medium term, Apr 25, 2025

Hovedindeksen has broken through the floor of a rising trend channel in the medium long term. This indicates a slower rising rate at first, or the start of a more horizontal development. The index is testing resistance at points 1460. This could give a negative reaction, but an upward breakthrough of points 1460 means a positive signal. The volume balance is negative and weakens the index in the short term. The index is overall assessed as technically slightly negative for the medium long term.

Recommendation one to six months: Weak Negative (Score: -45)

Period  
Vol.bal. Volatility Liquidity +/- %
1 day-0.60%5 746.48+0.29%
5 days-36.312.02%5 034.03+0.67%
22 days-56.104.85%5 910.88-5.08%
66 days-39.488.41%6 429.94-2.33%

More analyses of Hovedindeksen

chart Hovedindeksen (OSEBX) Candlesticks 22 Days
Candlesticks
chart Hovedindeksen (OSEBX) Short term
Short term: Negative
chart Hovedindeksen (OSEBX) Medium term
Medium term: Weak Negative
chart Hovedindeksen (OSEBX) Long term
Long term: Hold
 


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.

Titlex

OK
+

Cookie consent

We use cookies to give you a better user experience. If you continue to use the website, you accept this. For further details click here.